chr16-172854-C-T
Variant summary
Our verdict is Benign. Variant got -9 ACMG points: 0P and 9B. BP4_StrongBS1_SupportingBS2
The NM_000517.6(HBA2):c.-59C>T variant causes a upstream gene change involving the alteration of a non-conserved nucleotide. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_000517.6 upstream_gene
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -9 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
HBA2 | ENST00000251595.11 | c.-59C>T | upstream_gene_variant | 1 | NM_000517.6 | ENSP00000251595.6 | ||||
HBA2 | ENST00000484216.1 | c.-92C>T | upstream_gene_variant | 1 | ENSP00000495899.1 | |||||
HBA2 | ENST00000482565.1 | n.-40C>T | upstream_gene_variant | 1 | ||||||
HBA2 | ENST00000397806.1 | c.-106C>T | upstream_gene_variant | 2 | ENSP00000380908.1 |
Frequencies
GnomAD3 genomes AF: 0.00 AC: 0AN: 0Hom.: 0 Cov.: 0 FAILED QC
GnomAD4 exome AF: 0.00261 AC: 332AN: 127138Hom.: 12 Cov.: 0 AF XY: 0.00215 AC XY: 144AN XY: 67122
GnomAD4 genome Data not reliable, filtered out with message: AC0;AS_VQSR AF: 0.00 AC: 0AN: 0Hom.: 0 Cov.: 0 AF XY: 0.00 AC XY: 0AN XY: 0
ClinVar
Submissions by phenotype
HBA2-related disorder Uncertain:1
The HBA2 c.-59C>T variant is located in the 5' untranslated region. This variant resides within the 5' untranslated region within the TATA box and has previously been identified in an asymptomatic patient. In vitro transcriptional studies have shown this variant to decrease HBA2 transcription (Qadah et al 2014. PubMed ID: 24300714). This variant has not been reported in a large population database, indicating this variant is rare. At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. -
alpha Thalassemia;C0700299:Heinz body anemia;C3161174:Hemoglobin H disease;C4693823:Erythrocytosis, familial, 7 Uncertain:1
- -
not provided Uncertain:1
The HBA2 c.-59C>T variant has been reported in the published literature in a heterozygous state in individuals with alpha thalassemia (PMIDs: 35638908 (2022), 38708170 (2024)) as well as individuals with a normal clinical presentation (PMID: 24300714 (2014)). This variant occurs in the TATA box element of the promoter of the alpha2-globin gene and was found to cause an approximately 50% reduction in the level of transcription of the alpha2-globin gene (PMID: 24300714 (2014)). This variant has not been reported in large, multi-ethnic general populations (Genome Aggregation Database, http://gnomad.broadinstitute.org). Based on the available information, we are unable to determine the clinical significance of this variant. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at